SV Health Investors, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 94 filers reported holding OCULAR THERAPEUTIX INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 1.2%.

Quarter-by-quarter ownership
SV Health Investors, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2020$2,600,000
-16.4%
312,068
-50.3%
1.80%
-30.9%
Q1 2020$3,110,000
+25.3%
628,2360.0%2.61%
+73.5%
Q4 2019$2,482,000
+29.9%
628,2360.0%1.50%
+12.0%
Q3 2019$1,910,000
-30.9%
628,2360.0%1.34%
-27.7%
Q2 2019$2,764,000
+10.8%
628,2360.0%1.86%
+26.8%
Q1 2019$2,494,000
-0.2%
628,2360.0%1.46%
-4.9%
Q4 2018$2,500,000
-49.7%
628,236
-13.1%
1.54%
+5.7%
Q3 2018$4,974,000
-40.8%
722,936
-41.9%
1.46%
-62.3%
Q2 2018$8,406,000
-19.6%
1,245,270
-22.4%
3.86%
-50.8%
Q1 2018$10,449,000
+46.3%
1,605,2070.0%7.84%
+107.7%
Q4 2017$7,143,000
-28.0%
1,605,2070.0%3.77%
-49.8%
Q3 2017$9,920,000
-33.3%
1,605,2070.0%7.52%
-53.0%
Q2 2017$14,880,000
-0.1%
1,605,2070.0%16.02%
-2.7%
Q1 2017$14,896,000
+10.9%
1,605,2070.0%16.45%
+45.4%
Q4 2016$13,436,000
+1.2%
1,605,207
-16.9%
11.31%
+10.9%
Q3 2016$13,277,000
+38.8%
1,932,6070.0%10.20%
+5.6%
Q2 2016$9,566,000
-48.8%
1,932,6070.0%9.66%
-30.8%
Q1 2016$18,669,000
+3.1%
1,932,6070.0%13.95%
-4.2%
Q4 2015$18,109,000
-33.4%
1,932,6070.0%14.56%
-4.2%
Q3 2015$27,172,000
-33.1%
1,932,6070.0%15.20%
-2.3%
Q2 2015$40,643,000
-62.6%
1,932,607
-25.3%
15.56%
-56.6%
Q1 2015$108,570,000
+78.5%
2,585,6070.0%35.88%
+18.2%
Q4 2014$60,813,000
+57.1%
2,585,6070.0%30.34%
+57.1%
Q3 2014$38,707,0002,585,60719.31%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2020
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders